Cargando…

Translating imaging traits of mass-forming intrahepatic cholangiocarcinoma into the clinic: From prognostic to therapeutic insights

BACKGROUND & AIMS: The progress toward clinical translation of imaging biomarkers for mass-forming intrahepatic cholangiocarcinoma (MICC) is slower than anticipated. Questions remain on the biologic behaviour underlying imaging traits. We developed and validated imaging-based prognostic systems...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Gu-Wei, Xu, Qing, Jiao, Chen-Yu, Lu, Ming, Xu, Zheng-Gang, Zhang, Biao, Yang, Yue, Wang, Ke, Li, Xiang-Cheng, Wang, Xue-Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468367/ https://www.ncbi.nlm.nih.gov/pubmed/37663120 http://dx.doi.org/10.1016/j.jhepr.2023.100839

Ejemplares similares

Unusual Images of Mass-Forming Intrahepatic Cholangiocarcinoma
por: Takakura, Kazuki, et al.
Publicado: (2013)

Prognostic factors for patients with mass-forming intrahepatic cholangiocarcinoma: A case series of 68 patients
por: Feng, Jian, et al.
Publicado: (2022)

MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
por: Sammon, Jennifer, et al.
Publicado: (2018)

Contrast-enhanced multiple-phase imaging features of intrahepatic mass-forming cholangiocarcinoma and hepatocellular carcinoma with cirrhosis: A comparative study
por: Chen, Ying, et al.
Publicado: (2017)

Development and validation of a gradient boosting machine to predict prognosis after liver resection for intrahepatic cholangiocarcinoma
por: Ji, Gu-Wei, et al.
Publicado: (2022)

Patterns of Recurrence after Resection of Mass-Forming Type Intrahepatic Cholangiocarcinomas
por: Luvira, Vor, et al.
Publicado: (2016)

Prediction for early recurrence of intrahepatic mass-forming cholangiocarcinoma: quantitative magnetic resonance imaging combined with prognostic immunohistochemical markers
por: Zhao, Li, et al.
Publicado: (2019)

Dual-Specificity Phosphatase 11 Is a Prognostic Biomarker of Intrahepatic Cholangiocarcinoma
por: Xu, Lin, et al.
Publicado: (2021)

Prognostic Significance of Capn4 Overexpression in Intrahepatic Cholangiocarcinoma
por: Zhang, Chi, et al.
Publicado: (2013)

Radiomics Analysis of Contrast-Enhanced CT for the Preoperative Prediction of Microvascular Invasion in Mass-Forming Intrahepatic Cholangiocarcinoma
por: Xiang, Fei, et al.
Publicado: (2021)

Serum liver enzymes serve as prognostic factors in patients with intrahepatic cholangiocarcinoma
por: Zhang, Chenyue, et al.
Publicado: (2017)

Prognostic Impact of Cirrhosis in Patients with Intrahepatic Cholangiocarcinoma following Hepatic Resection
por: Jeong, Seogsong, et al.
Publicado: (2017)

Insights into the role of STAT3 in intrahepatic cholangiocarcinoma
por: Yang, Ranzhiqiang, et al.
Publicado: (2022)

Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma
por: DHANASEKARAN, RENUMATHY, et al.
Publicado: (2013)

A novel nomogram for the prediction of intrahepatic cholangiocarcinoma in patients with intrahepatic lithiasis complicated by imagiologically diagnosed mass
por: Chen, Gang, et al.
Publicado: (2018)

The diagnostic and prognostic value of UBE2T in intrahepatic cholangiocarcinoma
por: Yu, Hua, et al.
Publicado: (2020)

A Deep Learning Workflow for Mass-Forming Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma Classification Based on MRI
por: Liu, Yangling, et al.
Publicado: (2022)

Intrahepatic mass-forming cholangiocarcinoma growing in a giant hepatic hemangioma: A case report
por: Zhou, Mengqi, et al.
Publicado: (2019)

Clinical Staging of Mass‐Forming Intrahepatic Cholangiocarcinoma: Computed Tomography Versus Magnetic Resonance Imaging
por: Kim, Yeun‐Yoon, et al.
Publicado: (2021)

Integrative Analysis Defines Distinct Prognostic Subgroups of Intrahepatic Cholangiocarcinoma
por: Goeppert, Benjamin, et al.
Publicado: (2019)

Radiomics-based model for predicting early recurrence of intrahepatic mass-forming cholangiocarcinoma after curative tumor resection
por: Zhu, Yong, et al.
Publicado: (2021)

Staging and Prognostic Models for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Burkhart, Richard A., et al.
Publicado: (2017)

Prognostic impact of hepatitis B or C on intrahepatic cholangiocarcinoma
por: Seo, Jung Woong, et al.
Publicado: (2020)

Cirrhosis in intrahepatic cholangiocarcinoma: prognostic importance and impact on survival
por: Thakral, Nimish, et al.
Publicado: (2023)

A New Prognostic Model Covering All Stages of Intrahepatic Cholangiocarcinoma
por: Zhou, Shuang-Nan, et al.
Publicado: (2022)

Imaging Spectrum of Intrahepatic Mass-Forming Cholangiocarcinoma and Its Mimickers: How to Differentiate Them Using MRI
por: Kovač, Jelena Djokic, et al.
Publicado: (2022)

Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma
por: Yao, Xing, et al.
Publicado: (2012)

Intrahepatic Sarcomatoid Cholangiocarcinoma
por: Malhotra, Shalini, et al.
Publicado: (2010)

Asbestos and Intrahepatic Cholangiocarcinoma
por: Brandi, Giovanni, et al.
Publicado: (2020)

Management of Intrahepatic Cholangiocarcinoma
por: Kodali, Sudha, et al.
Publicado: (2021)

Association between Immunohistochemistry Markers and Tumor Features and Their Diagnostic and Prognostic Values in Intrahepatic Cholangiocarcinoma
por: He, Jiannan, et al.
Publicado: (2022)

Peritumoral ductular reaction can be a prognostic factor for intrahepatic cholangiocarcinoma
por: Shen, Zhenyang, et al.
Publicado: (2020)

Case Report: Primary lymphoepithelioma-like intrahepatic cholangiocarcinoma
por: Liu, Fei, et al.
Publicado: (2023)

Intrahepatic Cholangiocarcinoma: State of the Art of FGFR Inhibitors
por: Wu, Tianyu, et al.
Publicado: (2021)

Clinical outcomes and prognostic factors of stereotactic body radiation therapy for intrahepatic cholangiocarcinoma
por: Shen, Ze-Tian, et al.
Publicado: (2017)

The prognostic impact of preoperative body composition in perihilar and intrahepatic cholangiocarcinoma
por: Lurje, Isabella, et al.
Publicado: (2022)

Uses of Inflammatory Markers for Differentiation of Intrahepatic Mass-Forming Cholangiocarcinoma from Liver Abscess: Case-Control Study
por: Lee, Sun Chul, et al.
Publicado: (2020)

Characterization and prognostic significance of mortalin, Bcl-2 and Bax in intrahepatic cholangiocarcinoma
por: Kang, Qiang, et al.
Publicado: (2018)

Comparative performance of inflammation-based prognostic scores in patients operated for intrahepatic cholangiocarcinoma
por: Lin, Jiajia, et al.
Publicado: (2019)

ERCC1 Can Be a Prognostic Factor in Hilar Cholangiocarcinoma and Extrahepatic Bile Duct Cancer, But Not in Intrahepatic Cholangiocarcinoma
por: Park, Kyun Woo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_c061rdg9b9e4ne0b3sfpnemnue